EP0716614A4 - Treatment of human tumors by genetic transformation of human tumor cells - Google Patents

Treatment of human tumors by genetic transformation of human tumor cells

Info

Publication number
EP0716614A4
EP0716614A4 EP94926678A EP94926678A EP0716614A4 EP 0716614 A4 EP0716614 A4 EP 0716614A4 EP 94926678 A EP94926678 A EP 94926678A EP 94926678 A EP94926678 A EP 94926678A EP 0716614 A4 EP0716614 A4 EP 0716614A4
Authority
EP
European Patent Office
Prior art keywords
human
treatment
tumor cells
genetic transformation
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94926678A
Other languages
German (de)
French (fr)
Other versions
EP0716614A1 (en
Inventor
Edward J Oldfield
Zvi Ram
R Michael Blaese
Kenneth W Culver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of EP0716614A1 publication Critical patent/EP0716614A1/en
Publication of EP0716614A4 publication Critical patent/EP0716614A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP94926678A 1993-09-03 1994-09-02 Treatment of human tumors by genetic transformation of human tumor cells Withdrawn EP0716614A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11666993A 1993-09-03 1993-09-03
US116669 1993-09-03
PCT/US1994/009961 WO1995006486A1 (en) 1993-09-03 1994-09-02 Treatment of human tumors by genetic transformation of human tumor cells

Publications (2)

Publication Number Publication Date
EP0716614A1 EP0716614A1 (en) 1996-06-19
EP0716614A4 true EP0716614A4 (en) 1998-02-04

Family

ID=22368537

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94926678A Withdrawn EP0716614A4 (en) 1993-09-03 1994-09-02 Treatment of human tumors by genetic transformation of human tumor cells

Country Status (4)

Country Link
EP (1) EP0716614A4 (en)
JP (1) JPH09505557A (en)
CA (1) CA2169557A1 (en)
WO (1) WO1995006486A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555108B1 (en) 1990-09-14 2003-04-29 The General Hospital Corporation Implanting HSV-TK retrovirus producing cells to treat tumors
US6537541B1 (en) 1990-09-14 2003-03-25 The General Hospital Corporation Implantation of HSV-TK retrovirus producer cells to destroy glioma
CN1151186A (en) * 1994-05-02 1997-06-04 华盛顿大学 Thymidine kinase mutants
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
US7087582B1 (en) 1995-09-26 2006-08-08 Regents Of The University Of Michigan Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21
US6207648B1 (en) 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy
GB9801902D0 (en) 1998-01-29 1998-03-25 Cancer Res Campaign Tech A gene promoter
WO2000034497A2 (en) 1998-12-09 2000-06-15 The General Hospital Corporation Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
US6677155B1 (en) 1999-04-22 2004-01-13 The General Hospital Corporation Triple hybrid amplicon vector systems to generate retroviral packaging lines
US6770632B1 (en) 1999-07-16 2004-08-03 The General Hospital Corporation Folypolyglutamyl synthetase gene transfer to enhance antifolate
WO2002053576A1 (en) 2001-01-05 2002-07-11 The General Hospital Corporation Viral delivery system for infectious transfer of large genomic dna inserts
US10980896B2 (en) 2013-10-29 2021-04-20 President And Fellows Of Harvard College Methods and compositions for inhibiting oxidative stress

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4583538A (en) * 1984-05-04 1986-04-22 Onik Gary M Method and apparatus for stereotaxic placement of probes in the body utilizing CT scanner localization
US4813399A (en) * 1986-07-18 1989-03-21 Gordon Robert T Process for the treatment of neurological or neuromuscular diseases and development
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BRAIN NERVE (TOKYO), vol. 38, no. 6, 1986, pages 593 - 598 *
CULVER ET AL: "IN VIVO GENE TRANSFER WITH RETROVIRAL VECTOR-PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN TUMORS", SCIENCE, vol. 256, 1992, pages 1550 - 1552, XP002045618 *
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; OKAMOTO ET AL: "CLINICAL STUDIES OF ADOPTIVE IMMUNOTHERAPY OF HUMAN DISSEMINATED BRAIN TUMORS WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN 2", XP002045621 *
DATABASE MEDLINE FILE SERVER STN KARLSRUHE; PLUNKETT ET AL: "STEROTAXIC IMPLANTATION OF DISPERSED CELL SUSPENSIONS INTO BRAIN. A SYSTEMATIC APPRAISAL OF CELL PLACEMENT AND SURVIVAL", XP002045622 *
GILBERT ET AL: "CELL TRANSPLANTATION OF GENETICALLY ALTERED CELLS ON BIODEGRADABLE POLYMER SCAFFOLDS IN SYNGENEIC RATS", TRANSPLANTATION, vol. 56, August 1993 (1993-08-01), pages 423 - 427, XP002045620 *
JOURNAL OF NEUROSURGERY, vol. 69, no. 2, 1988, pages 228 - 233 *
RAM ET AL: "IN SITU RETROVIRAL-MEDIATED GENE TRANSFER FOR THE TREATMENT OF BRAIN TUMORS IN RATS", CANCER RESEARCH, vol. 53, 1 January 1993 (1993-01-01), pages 83 - 88, XP002045617 *
See also references of WO9506486A1 *
SHORT ET AL: "GENE DELIVERY TO GLIOMA CELLS IN RAT BRAIN BY GRAFTING OF A RETROVIRUS PACKAGING CELL LINE", JOURNAL OF NEUROSCIENCE RESEARCH, vol. 27, 1990, pages 427 - 433, XP002045619 *

Also Published As

Publication number Publication date
JPH09505557A (en) 1997-06-03
WO1995006486A1 (en) 1995-03-09
CA2169557A1 (en) 1995-03-09
EP0716614A1 (en) 1996-06-19

Similar Documents

Publication Publication Date Title
EP0831904A4 (en) Treatment and diagnosis of prostate cancer
EP0963207A4 (en) Il-12 gene therapy of tumors
AU4473596A (en) Methods of human prostate cancer diagnosis
AU6097094A (en) Antisense polynucleotide inhibition of human growth factor-sensitive cancer cells
AU3792293A (en) Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
EP0942742A4 (en) Therapeutic compositions for treatment of cancer
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
EP0716614A4 (en) Treatment of human tumors by genetic transformation of human tumor cells
AU5300396A (en) Radiation enhanced gene therapy for treatment of tumors
AU5460786A (en) Human tumor therapy
IL101410A0 (en) Formulation for the treatment of cancer
EP0722343A4 (en) Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines
EP0448677A4 (en) Treatment of colon cancer
AU1346488A (en) Arginine-depleted human tumor necrosis factor
IL107768A0 (en) Treatment of agricultural produce
ZA935647B (en) Treatment of sickle cell disease
GB9308166D0 (en) Cancer therapy
ZA93212B (en) Enzyme castration of animal and tumor treatment
GB9218711D0 (en) Skin cancer treatment
GB9217998D0 (en) Methods of treating cancer
ZA95508B (en) Use of flavolignans as adjuvants in tumour therapy
AU4417996A (en) Treatment of prostate cancer
EP0668771A4 (en) Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs.
GB2312375B (en) Agents for treatment of cancer
AU5778399A (en) Gene therapy for treatment of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19971218

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000403